Actually, IL-10 increases CD8 T cell infiltration and IFN-γ production, and favors effective T cell memory responses (105, 106), therefore, IL-10 may in gastric cancer be effective as an immunotherapy by potentiating the activity of antitumor CD8 T cells. The gene discussed is CD8A; the disease is gastric cancer.